Masimo Corporation (MASI) is a publicly traded Healthcare sector company. As of May 20, 2026, MASI trades at $178.81 with a market cap of $9.36B and a P/E ratio of -63.18. MASI moved +0.01% today. Year to date, MASI is +33.43%; over the trailing twelve months it is +14.48%. Its 52-week range spans $125.94 to $194.88. Analyst consensus is neutral with an average price target of $180.00. Rallies surfaces MASI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MASI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MASI recently traded at $178.81. Market cap is $9.36B. P/E ratio is -63.18. Revenue is $1.53B.
| Metric | Value |
|---|---|
| Price | $178.81 |
| Market Cap | $9.36B |
| P/E Ratio | -63.18 |
| EPS | $-2.83 |
| Dividend Yield | 1.00% |
| 52-Week High | $194.88 |
| 52-Week Low | $125.94 |
| Volume | 703.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.53B |
| Net Income | $-151.50M |
| Gross Margin | 61.90% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.53B | $-151.50M | $-2.83 |
| 2024 | $2.09B | $-304.90M | $-5.72 |
| 2023 | $2.05B | $81.50M | $1.54 |
| 2022 | $2.04B | $143.50M | $2.68 |
3 analysts cover MASI: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $180.00.